Upregulation of class IA PI3K signaling is frequently found in cancer and occurs through various mechanisms, including inactivation of the PI3K antagonizer phosphatase and tensin homolog (PTEN), overactivation of RTKs upstream of PI3K and gain-of-function somatic mutations in genes coding for catalytic subunits [9–11]. Here, PIK3CB is linked to cancer.